IX
List of participants
J.M. Baeyens: Department of Pharmacology, Faculty of Medicine, University of Granada, Avda. de Madrid s/n., 18012 GRANADA, Spain
J. Brodeur: Département de Médecine du Travail et Hygiene du Milieu, University of Montreal, Case Póstale 6218 Sucursale "A",
MONTREAL, P.Q. H3C 3J7, Canada
A.L. de Week: Institute of Clinical Immunology, Inselspital Bern, 3010 BERN, Switzerland
J.V. Castell: Research Center, Ciudad Sanitaria de la S.S. "La Fe", Avda. Campanar, 21, 46009 VALENCIA, Spain
B.P. du Souich: Department of Pharmacology, Faculty of Medicine, University of Montreal, Case Póstale 6128 Sucursale "A",
MONTREAL, P.Q. H3C 3J7, Canada
S. Erill: Esteve Foundation, Llobet i Vall-Llosera, 2, 08032 BARCELONA, Spain
M.J. González de Suso: Department of Clinical Pharmacology, Phar- macology National Centre, Carr. de Majadahonda a Pozuelo, Km. 2, 28220 MAJADAHONDA, MADRID, Spain
L. Hernández-Nieto: Department of Internal Medicine, Hospital General y Clínico, La Cuesta, LA LAGUNA, Tenerife
P. Juul: The Royal Danish School of Pharmacy, Department of Phar- macology, 2 Universitetsparken, DK-2100 COPENHAGEN 0, Denmark
B. Kobusch: Klinikum der Christian-Albrechts Universitat, Department of Internal Medicine, Schittenhelmstrasse, 12, 2300 KIEL, F.R.G.
R. Lauwerys: Université Catholique de Louvain, Faculté de Médecine, Unite de Toxicologie Industrielle et de Médecine du Travail, Clos Chapelle-aux-Champs 30 Bte. 30-54, 1200 BRUSSELS, Belgium
D. Mansuy: Université René Descartes, Laboratoire de Chimie et de Biochimie, Pharmacologiques et Toxicologiques, 45 rué des Saints Peres, 75270 PARIS CEDEX 06, France
B.D. Michael: Cancer Research Campaign, Gray Laboratory, Mount Vernon Hospital, NORTHWOOD, Middlesex HA6 2RN, U.K.
P. Moldeus: Department of Toxicology, Karolinska Institute, Doktors- ringen, 16, Box 60400, S-104 01 STOCKHOLM 60, Sweden
G.J. Mulder: Center for Bio-Pharmaceutical Sciences, University of Leiden, Sylvius Laboratories, P.O. Box 9503, 2300 RA LEIDEN, The Netherlands
E.E. Ohnhaus: Klinikum der Christian-Albrechts Universitat, Department of Internal Medicine, Schittenhelmstrasse, 12, 2300 KIEL, F.R.G.
O. Pelkonen: Department of Pharmacology, Univerity of Oulu, SF-90220 OULU 22, Finland
G.L. Plaa: Department of Pharmacology, Faculty of Medicine, Universi- ty of Montreal, Case Póstale 6128 Sucursale "A", MONTREAL, P.Q. H3C 3J7, Canada
F. Planas-Bohne: Institut fur Genetik und Toxikologie von Spaltstoffen, Kernforschungszentrum Karlsruhe GmbH, Postfach 3640, D-7500 KARLSRUHE 1, F.R.G.
L.F. Prescott: Regional Poisoning Treatment Center, University Depart- ment of Therapeutics and Clinical Pharmacology, The Royal Infir- mary, EDINBURGH EH3 9YW, U.K.
N.I. Redmond: Toxicology Department, Searle Research and Develop- ment, Sophia Antipolis, Boïte Póstale 23, 06561 VALBONNE CEDEX, France
M.M. Reidenberg: Division of Clinical Pharmacology, Cornell University Medical College, 1300 York Avenue, NEW YORK, N.Y. 10021, U.S.A.
F.J.C. Roe: 19 Marryat Road, Wimbledon Common, LONDON SW19 5BB, U.K.
XI
B.P. Schmid: ZYMA, S.A., Toxicology Department, CH-1260 NYON, Switzerland
H.U. Vainio: International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372 LYON CEDEX-08, France
P.G. Watanabe: Dow Chemical, U.S.A., Mammalian and Environmental Toxicology Research Laboratory, 1803 Building, MIDLAND, MI 47674, U.S.A.
T. Wieland: Max-Planck Institute for Medical Research, Jahnstrasse, 29, D-6900 HEIDELBERG, F.R.G.
G. Zbinden: Institute of Toxicology, Federal Institute of Technology, University of Zurich, Schorenstrasse 16, CH-8603 SCHWERZEN- BACH, Switzerland
